Platform Deployment for Clinical Trials
Various (Chronic Cough, IPF, Asthma, etc.)
Various Phases (I-III)Active
Key Facts
Indication
Various (Chronic Cough, IPF, Asthma, etc.)
Phase
Various Phases (I-III)
Status
Active
Company
About Strados Labs
Strados Labs is a Philadelphia-based digital health company founded in 2018, focused on transforming respiratory monitoring through its FDA 510(k)-cleared and CE-marked RESP® Platform. The company's core technology is a discreet, wearable biosensor that continuously captures high-fidelity lung sounds and physiological data, which is then analyzed in the cloud for clinical and research applications. Strados primarily serves the life sciences industry by providing digital endpoints for respiratory clinical trials and is expanding into remote patient monitoring, with its technology validated and deployed across numerous global clinical sites.
View full company profile